Tavella et al., 2004 - Google Patents
Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expressionTavella et al., 2004
View PDF- Document ID
- 10497751073378019818
- Author
- Tavella S
- Biticchi R
- Schito A
- Minina E
- Di Martino D
- Pagano A
- Vortkamp A
- Horton W
- Cancedda R
- Garofalo S
- Publication year
- Publication venue
- Journal of bone and mineral research
External Links
Snippet
Abstract The role of Hedgehogs (Hh) in murine skeletal development was studied by overexpressing human Sonic Hedgehog (SHH) in chondrocytes of transgenic mice using the collagen II promoter/enhancer. Overexpression caused a lethal craniorachischisis with …
- 210000001612 Chondrocytes 0 title abstract description 118
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tavella et al. | Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression | |
Yu et al. | Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth | |
Hattori et al. | SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification | |
Long et al. | Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton | |
St-Jacques et al. | Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation | |
Provot et al. | Nkx3. 2/Bapx1 acts as a negative regulator of chondrocyte maturation | |
Akiyama et al. | Interactions between Sox9 and β-catenin control chondrocyte differentiation | |
Arnold et al. | MEF2C transcription factor controls chondrocyte hypertrophy and bone development | |
Chung et al. | Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development | |
Mak et al. | Wnt/β-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation | |
Zanotti et al. | Notch inhibits osteoblast differentiation and causes osteopenia | |
Ehlen et al. | Inactivation of anoctamin‐6/Tmem16f, a regulator of phosphatidylserine scrambling in osteoblasts, leads to decreased mineral deposition in skeletal tissues | |
Tsumaki et al. | Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation | |
Später et al. | Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis | |
Wang et al. | Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription | |
Chen et al. | Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation | |
Wang et al. | IGF‐1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihh pathway | |
Zhang et al. | ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development | |
Ionescu et al. | FoxA family members are crucial regulators of the hypertrophic chondrocyte differentiation program | |
Kolanczyk et al. | Multiple roles for neurofibromin in skeletal development and growth | |
Bond et al. | Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature growth plate chondrocytes | |
Minina et al. | BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation | |
Takeda et al. | Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice | |
Lou et al. | A Runx2 threshold for the cleidocranial dysplasia phenotype | |
Okamoto et al. | Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development |